Prevalence of the MEFV Gene Mutations in Childhood Polyarteritis Nodosa
Objectives
To test the hypothesis that alterations in the Mediterranean fever (MEFV) gene are a susceptibility factor for the development of polyarteritis nodosa (PAN) we investigated the prevalence of MEFV mutations in patients with PAN without any symptoms of familial Mediterranean fever (FMF).
Study design
Pediatric patients with PAN (n = 29) were enrolled in this study. Six predominant mutations (p.M694V, p.M680I, p.M694I, p.V726A, p.K695R, p.E148Q) in the MEFV gene were studied.
Results
Fifteen MEFV mutations were identified in 58 chromosomes. Eleven of the 29 patients (38%) were found to carry MEFV mutations. Three (10.3%) of them had homozygous p.M694V mutation, and one of the patients (3.4%) had compound heterozygous mutation (p.V726A/p.E148Q).
Conclusions
Our study confirms that alterations in the MEFV gene are important succeptibility factors for the development of PAN. We believe that mutations in MEFV gene provide a basis for the development of PAN both by forming a proinflammatory state and by possibly giving exaggerated response to streptococcal infections.
Abbreviations: ASO, Antistreptolysin O, FMF, Familial Mediterranean fever, PAN, Polyarteritis nodosa
To access this article, please choose from the options below
PII: S0022-3476(07)00439-8
doi:10.1016/j.jpeds.2007.04.062
© 2007 Mosby, Inc. All rights reserved.
